Eli Lilly’s Sales Slash… And How To Position ...

Shares of Intel in rally mode, as the tech stock climbs 80% this year as investors eye its next earnings report on Thursday. The reasons behind the move, and why Wall Street is jumping on the band wagon. Plus United Airlines reports results, the Chartmaster hits Apple’s technical ...  Show more

Stocks kicking off the week snapping a major winning streak, as investors eye the next move in the fragile Mideast ceasefire. The details behind the latest developments, and the impact on oil as prices tick back up. Plus a combo in the construction supplies space, Eli Lilly’s lat ...  Show more

It’s been a year since Silicon Valley Bank’s collapse left everyone worried that the US’s banking sector sat on shaky ground. Despite that turmoil, one bank stands out: JPMorgan Chase. The largest bank in the country, JPMorgan took home record profits in 2023, and its dom ...

David Faber and Jim Cramer began the hour by breaking down another volatile day for the markets, with the major indices coming off their 4th negative session in 5. JPMorgan also raised their odds of a U.S. recession by year end to 35%. A big earnings mover today included Eli L ...

Chris Whalen, chairman of Whalen Global Advisors, returns to Forward Guidance to comment on the ample and growing earnings of the big banks (particularly JPMorgan Chase, whose stock surged over 7% on rosy net income and increasing deposits).  Whalen argues that banks’ unrealized ...  Show more

David Kostin, Goldman Sachs chief US equity strategist, says the group of Magnificent Seven stocks are now the Maleficent Seven and they've been a "real source of pain" in the market this year. Kostin lowered his 2025 year-end S&P 500 price target from 6,500 to 6,200. Kostin spea ...  Show more